Ábel has recently been diagnosed with Duchenne muscular dystrophy. This is a severe, rare genetic disease that causes gradual muscle weakness, followed by complete muscle atrophy, eventually leading to total muscle wasting. Abroad, there is a
 a special gene therapy that could stop this process, but at a cost of HUF 1.3 billion.

Ábel was born on 21 May 2019 in Miskolc, the second child of the family. He has a brother, Áron, with whom he has always had a loving relationship. He spent his first years as a cheerful, smiling, always moving little boy. Although his development was slightly slower than his peers, no one thought there was anything seriously wrong with him. In 2022, tests before a routine tonsillectomy revealed something was wrong: high CK levels and liver function abnormalities. Detailed tests were then carried out, which in 2023 finally confirmed the parents' worst fear: that Abel was suffering from Duchenne muscular dystrophy.

Since then, the family has been doing everything they can to slow the progress of the disease. Abel is currently on steroid treatment, which slows down the muscle breakdown but has serious side effects and is not a permanent solution. Gene therapy would be the only chance to stop Abel's condition from deteriorating further. Although it would not bring back the muscle mass already lost, it would stop the disease from worsening - ensuring that Abel can continue to live, move and play with his brother and loving family.

The parents - Edina and Tibor - are fighting for their son with all their strength, but they cannot face such a financial burden alone. They hope that with the help of well-meaning people, they can raise the money to pay for the treatment and give Abel the chance to live a longer, fuller life.

Let's help Abel and his family together!